About Pharmapace
Pharmapace is a Healthcare company based in San Diego (United States) founded in 2013, and was acquired by WuXi AppTec in May 2019. Integrated silicon photonics products are developed for optical communication applications. Pharmapace offers products and services including Biostatistics Services, Data Management, Statistical Programming, and Regulatory Submissions. Its focus areas include Biopharma Outsourcing, CRO, Clinical Development and Functional Services. Its legal entity is Pharmapace, Inc. Its competitors include SSI Strategy, Health Decisions and Antios Therapeutics; 1 of its 3 listed competitors has raised funding.
Company details
Founded in 2013 and based in San Diego, United States, Pharmapace operates in the silicon photonics sector. Components such as lasers, modulators, and photodiodes are designed and manufactured for ethernet modules, co-packaged optics, lidar systems, and biosensors. Wafer-scale integration is utilized to produce compact, hermetically sealed products with enhanced thermal performance. The platform is adapted for O- and C-band uses, supported by a high-volume silicon foundry for scalable production.
- Headquarters San Diego, United States
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website pharmapace.com
- Social LinkedIn Facebook
- Acquired by WuXi AppTec (May 2019)
- Legal Name Pharmapace, Inc.
- Investors
- Acquired byWuXi AppTec
(May 2019)
Products & Services of Pharmapace
Pharmapace offers a comprehensive portfolio of products and services, including Biostatistics Services, Data Management, Statistical Programming, and Regulatory Submissions.
Offers statistical planning and analysis for clinical trials
Manages clinical data for drug development processes
Develops programs for data analysis in research studies
Handles submissions for drug approvals and compliance
Investors in Pharmapace
Pharmapace has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include WuXi AppTec.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Provider of CRO and CDMO services | 2000 | wuxiapptec.com | Shanghai, China |
Investor details for Pharmapace
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Pharmapace
2 dated milestones of Pharmapace across 6 years, from founding to its latest funding, stage changes and deals.
- Founded Pharmapace is founded.
- Exit Acquired by WuXi AppTec.
Competitors of Pharmapace
Pharmapace has 3 listed competitors in our database, 1 of them funded. They include SSI Strategy, Health Decisions and Antios Therapeutics.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| ssistrategy.com | 2010 | Parsippany Troy Hills, United States | Pharmacovigilance and medical affairs services are offered for drug development. | |||
| healthdec.com | 1989 | Durham, United States | 110 | CRO focused on clinical trial services for data management, monitoring and biostatistics | ||
| antiostherapeutics.com | 2018 | Atlanta, United States | $200.4M | Innovative therapies for treating and curing viral diseases are developed. |
Detailed competitors of Pharmapace
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Pharmapace (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Pharmapace
Pharmapace was founded in 2013.
Pharmapace is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Founded in 2013 and based in San Diego, United States, Pharmapace operates in the silicon photonics sector. Components such as lasers, modulators, and photodiodes are designed and manufactured for ethernet modules, co-packaged optics, lidar systems, and biosensors. Wafer-scale integration is utilized to produce compact, hermetically sealed products with enhanced thermal performance. The platform is adapted for O- and C-band uses, supported by a high-volume silicon foundry for scalable production.
Pharmapace's top competitors include SSI Strategy, Health Decisions and Antios Therapeutics.
Pharmapace offers Biostatistics Services, Data Management, Statistical Programming, and Regulatory Submissions.
Pharmapace has 1 investor. Key investors include WuXi AppTec.
Pharmapace operates through Pharmapace, Inc..
Yes. Pharmapace was acquired by WuXi AppTec in May 2019.